Samsung Biologics Appoints Gail Ward, Vice President with 38 Years of Quality Control Experience

Global Pharmaceutical Company Veteran with 38 Years of Experience... Quality Expert
Lee So-jeong Appointed as Head of Regulatory Affairs

Samsung Biologics announced on the 24th that it will recruit Gail Ward from the US biotech company ProKidney as the Head of the Quality Operations Center (Vice President).

Vice President Ward, who is scheduled to assume the position on the 1st of next month, is a US national and a seasoned quality management expert with 38 years of expertise in the quality field at leading global pharmaceutical companies.

Vice President Ward began her career in quality assurance (QA) in 1984 at Redry Praxis Biologics in the US, and subsequently worked at global pharmaceutical companies Biogen and Dyosinse. From 2005 to 2014, she worked at Celltrion, where she served as Vice President in charge of quality from 2010 to 2014. Since 2016, she has overseen quality management at ProKidney, a biotech company researching treatments for chronic kidney disease using patients' cells.

Additionally, Samsung Biologics has recruited Sojeong Lee, Executive Director (Team Leader), as the head of global regulatory approvals under the Quality Operations Center. According to the company, Executive Director Lee is an expert who has accumulated diverse experience related to regulatory approvals through her work at Yuhan Corporation and GlaxoSmithKline (GSK), among others.

Samsung Biologics plans to focus on enhancing the quality competitiveness of biopharmaceuticals based on the quality management expertise and know-how possessed by Vice President Ward and Executive Director Lee.

Gael Ward, Vice President and Head of Quality Operations Center at Samsung Biologics, and Sojeong Lee, Executive Director (Team Leader). (From left) [Photo by Samsung Biologics]

This content was produced with the assistance of AI translation services.